After finishing at $0.43 in the prior trading day, PAVmed Inc. (NASDAQ: PAVM) closed at $0.41, down -4.42%. In other words, the price has decreased by -$0.0190 from its previous closing price. On the day, 542467 shares were traded. PAVM stock price reached its highest trading level at $0.4525 during the session, while it also had its lowest trading level at $0.4110.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our goal is to gain a better understanding of PAVM by taking a closer look at its different ratios.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 07 when Glennon Michael J bought 100,000 shares for $0.62 per share. The transaction valued at 62,320 led to the insider holds 250,000 shares of the business.
Glennon Michael J bought 88,000 shares of PAVM for $56,082 on Dec 06. The Director now owns 150,000 shares after completing the transaction at $0.64 per share. On Dec 05, another insider, Glennon Michael J, who serves as the Director of the company, bought 62,000 shares for $0.69 each. As a result, the insider paid 42,606 and bolstered with 62,000 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PAVM now has a Market Capitalization of 44.05M and an Enterprise Value of 43.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 71.25. Its current Enterprise Value per Revenue stands at 68.83 whereas that against EBITDA is -0.43.
Stock Price History:
Over the past 52 weeks, PAVM has reached a high of $2.34, while it has fallen to a 52-week low of $0.35. The 50-Day Moving Average of the stock is 0.4428, while the 200-Day Moving Average is calculated to be 0.7456.
The stock has traded on average 425.06K shares per day over the past 3-months and 525.93k shares per day over the last 10 days, according to various share statistics. A total of 97.09M shares are outstanding, with a floating share count of 83.40M. Insiders hold about 0.30% of the company’s shares, while institutions hold 13.70% stake in the company. Shares short for PAVM as of Apr 27, 2023 were 5.15M with a Short Ratio of 5.15M, compared to 5.57M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.23% and a Short% of Float of 5.63%.
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.16 and a low estimate of -$0.21, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.13 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.6 and -$1 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.6, with 3 analysts recommending between -$0.49 and -$0.66.
A total of 4 analysts have provided revenue estimates for PAVM’s current fiscal year. The highest revenue estimate was $8.5M, while the lowest revenue estimate was $1.8M, resulting in an average revenue estimate of $4.31M. In the same quarter a year ago, actual revenue was $377k, up 1,043.20% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $11.51M in the next fiscal year. The high estimate is $19.4M and the low estimate is $4.6M. The average revenue growth estimate for next year is up 167.10% from the average revenue estimate for this year.